Although African Americans are 1.4 times more likely to carry the APOE-ε4 allele than European Americans (Rajan et al., 2014), its effect on AD development is diminished in African ancestry groups (Hendrie et al., 2014; Rajabli et al., 2018). This evidence concerns the gene APOE and Alzheimer disease.